These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 7534294

  • 41. Lipopolysaccharide-binding protein and phospholipid transfer protein release lipopolysaccharides from gram-negative bacterial membranes.
    Vesy CJ, Kitchens RL, Wolfbauer G, Albers JJ, Munford RS.
    Infect Immun; 2000 May; 68(5):2410-7. PubMed ID: 10768924
    [Abstract] [Full Text] [Related]

  • 42. CD14-mediated translocation of nuclear factor-kappa B induced by lipopolysaccharide does not require tyrosine kinase activity.
    Delude RL, Fenton MJ, Savedra R, Perera PY, Vogel SN, Thieringer R, Golenbock DT.
    J Biol Chem; 1994 Sep 02; 269(35):22253-60. PubMed ID: 7520914
    [Abstract] [Full Text] [Related]

  • 43. Lipopolysaccharide binding protein and CD14 in LPS dependent macrophage activation.
    Tobias PS, Ulevitch RJ.
    Immunobiology; 1993 Apr 02; 187(3-5):227-32. PubMed ID: 7687234
    [Abstract] [Full Text] [Related]

  • 44. Modulatory effects of sCD14 and LBP on LPS-host cell interactions.
    Kitchens RL, Thompson PA.
    J Endotoxin Res; 2005 Apr 02; 11(4):225-9. PubMed ID: 16176659
    [Abstract] [Full Text] [Related]

  • 45. The molecular basis for therapeutic concepts utilizing CD14.
    Stelter F, Bernheiden M, Menzel R, Witt S, Jack RS, Grunwald U, Fan X, Schütt C.
    Prog Clin Biol Res; 1998 Apr 02; 397():301-13. PubMed ID: 9575571
    [Abstract] [Full Text] [Related]

  • 46. Analysis of lipopolysaccharide binding by CD14.
    Kirkland TN, Finley F, Leturcq D, Moriarty A, Lee JD, Ulevitch RJ, Tobias PS.
    J Biol Chem; 1993 Nov 25; 268(33):24818-23. PubMed ID: 7693705
    [Abstract] [Full Text] [Related]

  • 47.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 48. Neither CD14 nor serum is absolutely necessary for activation of mononuclear phagocytes by bacterial lipopolysaccharide.
    Lynn WA, Liu Y, Golenbock DT.
    Infect Immun; 1993 Oct 25; 61(10):4452-61. PubMed ID: 7691750
    [Abstract] [Full Text] [Related]

  • 49. Control of lipopolysaccharide (LPS) binding and LPS-induced tumor necrosis factor secretion in human peripheral blood monocytes.
    Heumann D, Gallay P, Barras C, Zaech P, Ulevitch RJ, Tobias PS, Glauser MP, Baumgartner JD.
    J Immunol; 1992 Jun 01; 148(11):3505-12. PubMed ID: 1375247
    [Abstract] [Full Text] [Related]

  • 50. Interaction between CD14 lipopolysaccharide binding protein and bactericidal/permeability-increasing protein during lipopolysaccharide-induced cell activation.
    Dentener MA, Von Asmuth EJ, Francot GJ, Buurman WA.
    Prog Clin Biol Res; 1994 Jun 01; 388():59-70. PubMed ID: 7530372
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52. Helicobacter pylori and Porphyromonas gingivalis lipopolysaccharides are poorly transferred to recombinant soluble CD14.
    Cunningham MD, Seachord C, Ratcliffe K, Bainbridge B, Aruffo A, Darveau RP.
    Infect Immun; 1996 Sep 01; 64(9):3601-8. PubMed ID: 8751905
    [Abstract] [Full Text] [Related]

  • 53.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. Participation of lipopolysaccharide-binding protein in lipopolysaccharide-dependent macrophage activation.
    Tobias PS, Mathison J, Mintz D, Lee JD, Kravchenko V, Kato K, Pugin J, Ulevitch RJ.
    Am J Respir Cell Mol Biol; 1992 Sep 01; 7(3):239-45. PubMed ID: 1381594
    [Abstract] [Full Text] [Related]

  • 56.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 57. Interaction of SP-A (surfactant protein A) with bacterial rough lipopolysaccharide (Re-LPS), and effects of SP-A on the binding of Re-LPS to CD14 and LPS-binding protein.
    García-Verdugo I, Sánchez-Barbero F, Soldau K, Tobias PS, Casals C.
    Biochem J; 2005 Oct 01; 391(Pt 1):115-24. PubMed ID: 15932345
    [Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 60. Rough and smooth forms of fluorescein-labelled bacterial endotoxin exhibit CD14/LBP dependent and independent binding that is influencedby endotoxin concentration.
    Triantafilou M, Triantafilou K, Fernandez N.
    Eur J Biochem; 2000 Apr 01; 267(8):2218-26. PubMed ID: 10759844
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.